Resveratrol as an anticancer nutrient: molecular basis, open questions and promises
P Signorelli, R Ghidoni - The Journal of nutritional biochemistry, 2005 - Elsevier
The polyphenol resveratrol is an anticancer nutrient that was shown to inhibit cancer
initiation and promotion [Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW …
initiation and promotion [Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW …
Resveratrol: preventing properties against vascular alterations and ageing
D Delmas, B Jannin, N Latruffe - Molecular nutrition & food …, 2005 - Wiley Online Library
Cardiovascular diseases are the leading cause of death in developed countries where the
common pathological substrate underlying this process is atherosclerosis. Several new …
common pathological substrate underlying this process is atherosclerosis. Several new …
Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells
IZ Jaffe, ME Mendelsohn - Circulation research, 2005 - Am Heart Assoc
Inhibition or blockade of the angiotensin-aldosterone system consistently decreases
ischemic cardiovascular events in clinical trials. The steroid hormone aldosterone acts by …
ischemic cardiovascular events in clinical trials. The steroid hormone aldosterone acts by …
Phytoestrogens induce differential estrogen receptor alpha-or beta-mediated responses in transfected breast cancer cells
DM Harris, E Besselink, SM Henning… - Experimental …, 2005 - journals.sagepub.com
Increased intake of phytoestrogens may be associated with a lower risk of cancer in the
breast and several other sites, although there is controversy surrounding this activity. One of …
breast and several other sites, although there is controversy surrounding this activity. One of …
Modification of the estrogenic properties of diphenols by the incorporation of ferrocene. Generation of antiproliferative effects in vitro
We report here the synthesis and the strong and unexpected antiproliferative effect of the
organometallic diphenolic compound 1, 1-bis (4 '-hydroxyphenyl)-2-ferrocenyl-but-1-ene (4) …
organometallic diphenolic compound 1, 1-bis (4 '-hydroxyphenyl)-2-ferrocenyl-but-1-ene (4) …
Resveratrol and breast cancer chemoprevention: molecular mechanisms
L Le Corre, N Chalabi, L Delort… - Molecular nutrition & …, 2005 - Wiley Online Library
Despite years of intensive research, breast cancer remains a major cause of death among
women. New strategies to combat breast cancer are being developed, one of the most …
women. New strategies to combat breast cancer are being developed, one of the most …
[图书][B] Resveratrol in health and disease
BB Aggarwal, S Shishodia - 2005 - books.google.com
Practicing evidenced-based medicine some 25 centuries ago, Hippocrates proclaimed" Let
food be thy medicine and medicine be thy food." This advice parallels the common American …
food be thy medicine and medicine be thy food." This advice parallels the common American …
[PDF][PDF] The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor alpha in human breast cancer cells
M Maggiolini, AG Recchia, D Bonofiglio… - Journal of …, 2005 - jme.bioscientifica.com
Previous epidemiological reports have suggested that red wine intake is associated with
beneficial health effects due to the ability of certain phytochemical components to exert …
beneficial health effects due to the ability of certain phytochemical components to exert …
Resveratrol as cardioprotective agent: evidence from bench and bedside
S Burjonroppa, K Fujise - Resveratrol in Health and Disease, 2005 - taylorfrancis.com
This chapter examines epidemiological, clinical, translational, and basic scientific evidence
that supports resveratrol as a cardioprotective agent, reviewing selected key references …
that supports resveratrol as a cardioprotective agent, reviewing selected key references …
Resveratrol as an inhibitor of carcinogenesis
JM Pezzuto - Resveratrol in Health and Disease, 2005 - taylorfrancis.com
Cancer chemopreventive agents have been classified according to the stage of
carcinogenesis in which they have demonstrated activity, and broadly termed blocking and …
carcinogenesis in which they have demonstrated activity, and broadly termed blocking and …